Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine

International Journal of Cardiology

Volumn 132, Issue 3, 2009, Pages 348-353

  Ezenwaka, C E ^a   Nwagbara, E ^b   Seales, D ^a   Okali, F ^b   Hussaini, S ^b   Raja, Bn ^b   Jones LeCointe, A ^a   Sell, H ^c   Avci, H ^c   Eckel, J ^c  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b Tobago Regional Health Authority   (Trinidad and Tobago)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Caribbean; Coronary heart disease; Diabetes complications; Type 2 diabetes

Indexed keywords

CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; ETHNICITY; FEMALE; HUMAN; INDIAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING HABIT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRINIDAD AND TOBAGO; UNITED KINGDOM PROSPECTIVE DIABETES STUDY RISK ENGINE CALCULATOR;

AGED; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PRIMARY PREVENTION; RISK ASSESSMENT; SECONDARY PREVENTION; STROKE; TRINIDAD AND TOBAGO;

EID: 60949112771     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.12.005     Document Type: Article

References (30)

1. Central Statistical Office. Republic of Trinidad and Tobago. Office of the Prime Minister. Population and Housing Census vol. II: Age Structure, Religion, Ethnic Group, Education, Port of Spain: Central Statistical Office, 1998.
2. International Diabetes Federation. Diabetes atlas. Second Edition vol. 51 (2003)
3. Miller G.J., Beckles G.L., Maude G.H., et al. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James Survey, Trinidad. Int J Epidemiol 18 (1989) 808-817
4. Miller G.J., Maude G.H., and Beckles G. Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Comm Health 50 (1996) 497-504
5. Ezenwaka C.E., and Davis G. Increased cardiovascular risk factors in newly diagnosed type 2 diabetic patients in a primary health care center in Trinidad. Diabetes Res Clin Pract 50 2 (2000) 137-145
6. The Government of the Republic of Trinidad and Tobago. Ministry of Planning and Development, Central Statistical Office, Population, Social and Vital Statistics, Five Leading Causes of Death 1999, official website: http://www.cso.gov.tt/.
7. Haffner S.M., Lehto S., Ronnemaa T., et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 4 (1998) 229-234
8. Downs J.R., Clearfield M., Weis S., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 20 (1998) 1615-1622
9. Sanmuganathan P.S., Ghahramani P., Jackson P.R., et al. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 85 3 (2001) 265-271
10. Joint British Societies. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society. Joint British recommendations on prevention of coronary heart disease in Clinical practice. Heart 80 (1998) S1-S29
11. Anderson K.M., Odell P.M., Wilson P.W., et al. Cardiovascular disease risk profiles. Am Heart J 121 1 Pt 2 (1991) 293-298
12. Stevens R.J., Kothari V., Adler A.I., and Stratton I.M. United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond) 101 6 (2001) 671-679
13. Song S.H., and Brown P.M. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications. Diabet Med 21 3 (2004) 238-245
14. National Institute for Clinical Excellence. Management of type 2 diabetes: management of blood pressure and blood lipids. London National Institute for Clinical Excellence (NICE) (2002)
15. Stratton I.M., Alder A.I., Neil H., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
16. Bonora E., and Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 44 12 (2001) 2107-2114
17. Ezenwaka C.E., and Offiah N.V. Differences in glycemic control and cardiovascular risk in primary care patients with type 2 diabetes in West Indies. Clin Exp Med 1 2 (2001) 91-98
18. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 7-22
19. Ong H.T. Evidence-based prescribing of statin: a developing world perspective. PLoS Med 3 3 (2006) e50
20. Lip G., Malik I., Luscombe C., et al. Dietary fat purchasing habits in Whites, Blacks and Asian peoples in England - implications for heart disease prevention. Int J Cardiol 48 3 (1995) 287-293
21. Forouhi N.G., and Sattar N. CVD risk factors and ethnicity - a homogeneous relationship. Atheroscler Suppl 7 1 (2006) 11-19
22. Palaniappan L., Wang Y., and Fortmann S.P. Coronary heart disease mortality for six ethnic groups in California, 1990-2000. Ann Epidemiol 14 7 (2004) 499-506
23. Ruland S., Richardson D., Hung E., et al. AAASPS Investigators. Predictors of recurrent stroke in African Americans. Neurology 67 4 (2006) 567-571
24. Shaya F.T., El Khoury A.C., Mullins C.D., et al. Drug therapy persistence and stroke recurrence. Am J Manag Care 12 6 (2006) 313-319
25. Howard G., Prineas R., Moy C., et al. Racial and geographic differences in awareness, treatment, and control of hypertension: The Reasons for Geographic and Racial Differences in Stroke Study. Stroke 37 5 (2006) 1171-1178
26. Ezenwaka C.E., and Kalloo R. Glycaemic responses after ingestion of 3 local carbohydrate-based foods in West Indian patients with type-2 diabetes mellitus. Clin Nutr 23 4 (2004) 631-640
27. Yeo W.W., and Yeo K.R. Workload implications and cost of statin treatment in the NSF for coronary heart disease: guidance to setting a local statin policy. Br J Cardiol 7 (2000) S11-S18
28. World Health Organisation (WHO). Prevention of coronary heart disease: Report of a WHO Expert Committee. WHO Technical Report Series No 678, Geneva (1982)
29. Gaziano T.A., Opie L.H., and Weinstein M.C. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. Lancet 368 9536 (2006) 679-686
30. Combination Pharmacotherapy and Public Health Research Working Group. Combination pharmacotherapy for cardiovascular disease. Ann Intern Med 143 8 (2005) 593-599